Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter

Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as against Rs 0.11 crore during the previous quarter ended June 2023. Sales declined 3.45% to Rs 17.05 crore in the quarter ended June 2024 as against Rs 17.66 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	17.05	17.66	-3
OPM %	2.40	2.04	-
PBDT	0.43	0.33	30
PBT	0.27	0.21	29
NP	0.17	0.11	55